An anonymous director reports
SERENAS LAWSUIT AMENDED TO REMOVE CLAIM FOR 10,270,437 SHARES OR $5,546,035 AS AGAINST EXPERION HOLDINGS LTD
Experion Holdings Ltd., formerly Viridium Pacific Group Ltd., has released an update with respect to the litigation launched by Stephen Serenas and Pacific Executive Capital Corp., previously reported by the company on June 8, 2019. The plaintiffs have filed an amended notice of civil claim with the British Columbia Supreme Court that has removed the claim for 10,270,437 shares, or, alternatively, $5,546,035, as against Experion Holdings and its wholly owned subsidiary, Experion Biotechnologies Inc. Accordingly, the plaintiffs are no longer seeking an order for 10,270,437 shares, or, alternatively, $5,546,035, from either Experion Holdings or Experion Biotechnologies (they continue to seek this relief from other defendants). By means of various allegations in the amended notice of civil claim, the plaintiffs are continuing to pursue Experion Holdings and Experion Biotechnologies for wrongful dismissal and other relief, including 149,625 restricted stock units. Experion Holdings and Experion Biotechnologies intend to continue to vigorously defend against the remaining claims.
About Experion Holdings Ltd.
Experion Holdings is the parent company of Experion Biotechnologies, a Health Canada licensed cultivator and processor of cannabis based in Mission, B.C., and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, Alta.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.